Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Bolus Insulin Mar 28 | 2019Thoughts on Lilly Drug Pricing TransparencyPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Mar 27 | 2019Glytec Partners with Dario For Outpatient Insulin TitrationPurchase Blast$599
Posted in: SGLT2i Mar 25 | 2019Forxiga T1DM Approved in Europe; Sota EU T1DM Approval ImminentPurchase Blast$599
Posted in: Dual/triple agonist Mar 21 | 2019OPKO Oxyntomodulin Ph2 Data; Is It Commercially Viable?Purchase Blast$599
Posted in: Dual/triple agonist Mar 21 | 2019New Lilly Tirzepatide vs. Tresiba Ph3 Pivotal Study (SURPASS-3)Purchase Blast$599
Posted in: GLP-1RA Mar 20 | 2019Thoughts on Oral Sema and Ozempic Filings; 3 NDAs to De-risk Regulatory UncertaintyPurchase Blast$599
Posted in: GLP-1RA Mar 18 | 2019Novo-Teva Generic Victoza Settled; Launch Date Rationale UnclearPurchase Blast$599
Posted in: Bolus Insulin Mar 15 | 2019Potential Sanofi Bs-Aspart US Regulatory Strategy; New Interchangeability TrialPurchase Blast$599
Posted in: SGLT2i Mar 13 | 2019Lexicon Quiet on Sota T1DM Review; Q4 '18 Earnings UpdatePurchase Blast$599
Posted in: Glucose Monitoring Mar 12 | 2019New Eversense Bridge Program; Senseonics Q4 '18 Earnings UpdatePurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Other Mar 12 | 2019Adocia Q4 '18 Earnings Update; No Call ConductedPurchase Blast$599
Posted in: Other Mar 12 | 2019Zafgen Q4 '18 Earnings Update; ZGN-1258 Discontinued in PWSPurchase Blast$599
Posted in: DPP-IVi, Dual/triple agonist, GLP-1RA, Other, SGLT2i Mar 11 | 2019New Head of AZ CVRMPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Mar 08 | 2019Thoughts on Potential Livongo IPOPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.